{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:02:25Z","timestamp":1791406945646,"version":"4.3.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Quanzhou Science and Technology Plan Project, Fujian Province","award":["2020N017s"],"award-info":[{"award-number":["2020N017s"]}]},{"name":"Natural Science Foundation of Fujian Province,China","award":["2024J01121796"],"award-info":[{"award-number":["2024J01121796"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24958-w","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:26:10Z","timestamp":1763637970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["METTL3-mediated m6A modification of LINC00857 enhances stemness and metastasis of ovarian cancer cells by activating the YAP-TEAD pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Xueke","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"4","key":"24958_CR1","first-page":"280","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux, S., Braunstein, M. & Oza, A. M. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J. Clin. 69 (4), 280\u2013304 (2019).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"24958_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"10177","key":"24958_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux, S. et al. Epithelial ovarian cancer. Lancet 393 (10177), 1240\u20131253 (2019).","journal-title":"Lancet"},{"issue":"3","key":"24958_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ygyno.2018.06.020","volume":"150","author":"LA Meyer","year":"2018","unstructured":"Meyer, L. A. et al. Neoadjuvant chemotherapy in elderly women with ovarian cancer: rates of use and effectiveness. Gynecol. Oncol. 150 (3), 451\u2013459 (2018).","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"24958_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s10020-022-00521-5","volume":"28","author":"SL He","year":"2022","unstructured":"He, S. L. et al. LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter. Mol. Med. 28 (1), 112 (2022).","journal-title":"Mol. Med."},{"issue":"2","key":"24958_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan, Y. T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. (Lond). 41 (2), 109\u2013120 (2021).","journal-title":"Cancer Commun. (Lond)"},{"key":"24958_CR7","doi-asserted-by":"publisher","first-page":"996686","DOI":"10.3389\/fphar.2022.996686","volume":"13","author":"X Ren","year":"2022","unstructured":"Ren, X. et al. Exploring the oncogenic roles of LINC00857 in pan-cancer. Front. Pharmacol. 13, 996686 (2022).","journal-title":"Front. Pharmacol."},{"key":"24958_CR8","doi-asserted-by":"publisher","first-page":"215976","DOI":"10.1016\/j.canlet.2022.215976","volume":"552","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer. Cancer Lett. 552, 215976 (2023).","journal-title":"Cancer Lett."},{"issue":"2","key":"24958_CR9","first-page":"2119","volume":"16","author":"K Pang","year":"2018","unstructured":"Pang, K. et al. Long non-coding RNA LINC00857 promotes gastric cancer cell proliferation and predicts poor patient survival. Oncol. Lett. 16 (2), 2119\u20132124 (2018).","journal-title":"Oncol. Lett."},{"issue":"21","key":"24958_CR10","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1002\/cam4.3322","volume":"9","author":"X Lin","year":"2020","unstructured":"Lin, X. et al. LncRNA LINC00857 regulates the progression and Glycolysis in ovarian cancer by modulating the Hippo signaling pathway. Cancer Med. 9 (21), 8122\u20138132 (2020).","journal-title":"Cancer Med."},{"key":"24958_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canlet.2020.11.010","volume":"500","author":"C Shen","year":"2021","unstructured":"Shen, C. et al. Long non-coding rnas: emerging regulators for chemo\/immunotherapy resistance in cancer stem cells. Cancer Lett. 500, 244\u2013252 (2021).","journal-title":"Cancer Lett."},{"issue":"1","key":"24958_CR12","doi-asserted-by":"publisher","first-page":"113149","DOI":"10.1016\/j.yexcr.2022.113149","volume":"416","author":"J Liu","year":"2022","unstructured":"Liu, J., Yuan, J. F. & Wang, Y. Z. METTL3-stabilized LncRNA SNHG7 accelerates Glycolysis in prostate cancer via SRSF1\/c-Myc axis. Exp. Cell. Res. 416 (1), 113149 (2022).","journal-title":"Exp. Cell. Res."},{"issue":"3","key":"24958_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41418-021-00879-9","volume":"29","author":"HT Liu","year":"2022","unstructured":"Liu, H. T. et al. LncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus. Cell. Death Differ. 29 (3), 627\u2013641 (2022).","journal-title":"Cell. Death Differ."},{"key":"24958_CR14","doi-asserted-by":"publisher","first-page":"1004212","DOI":"10.3389\/fonc.2022.1004212","volume":"12","author":"Z Song","year":"2022","unstructured":"Song, Z. et al. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Front. Oncol. 12, 1004212 (2022).","journal-title":"Front. Oncol."},{"key":"24958_CR15","doi-asserted-by":"publisher","first-page":"629947","DOI":"10.3389\/fonc.2021.629947","volume":"11","author":"X Meng","year":"2021","unstructured":"Meng, X. et al. m(6)A-Mediated upregulation of LINC00857 promotes pancreatic cancer tumorigenesis by regulating the miR-150-5p\/E2F3 axis. Front. Oncol. 11, 629947 (2021).","journal-title":"Front. Oncol."},{"issue":"9","key":"24958_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41580-023-00612-z","volume":"24","author":"L Ma","year":"2023","unstructured":"Ma, L. & Zhang, Z. The contribution of databases towards Understanding the universe of long non-coding RNAs. Nat. Rev. Mol. Cell. Biol. 24 (9), 601\u2013602 (2023).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"7","key":"24958_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41419-022-05050-x","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. m6A methyltransferase METTL3-induced LncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression. Cell. Death Dis. 13 (7), 657 (2022).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"24958_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13048-021-00857-2","volume":"14","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5. J. Ovarian Res. 14 (1), 109 (2021).","journal-title":"J. Ovarian Res."},{"issue":"11","key":"24958_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1159\/000452263","volume":"39","author":"Y Miao","year":"2016","unstructured":"Miao, Y. et al. Prognostic significance of preoperative prognostic nutritional index in epithelial ovarian cancer patients treated with Platinum-Based chemotherapy. Oncol. Res. Treat. 39 (11), 712\u2013719 (2016).","journal-title":"Oncol. Res. Treat."},{"issue":"9","key":"24958_CR20","doi-asserted-by":"publisher","first-page":"7790","DOI":"10.1002\/jcb.27158","volume":"119","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. The LncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9. J. Cell. Biochem. 119 (9), 7790\u20137799 (2018).","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"24958_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/CAD.0000000000001288","volume":"33","author":"W Fang","year":"2022","unstructured":"Fang, W. & Xia, Y. LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p\/PEG3 axis. Anticancer Drugs. 33 (7), 671\u2013681 (2022).","journal-title":"Anticancer Drugs"},{"key":"24958_CR22","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. lncRNA SNHG15 promotes ovarian cancer progression through regulated CDK6 via sponging miR-370-3 Biomed Res Int, 2021: 9394563. (2021).","DOI":"10.1155\/2021\/9394563"},{"issue":"1","key":"24958_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-021-01993-x","volume":"21","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p\/SDC4 axis. Cancer Cell. Int. 21 (1), 284 (2021).","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"24958_CR24","doi-asserted-by":"publisher","first-page":"108597","DOI":"10.1016\/j.celrep.2020.108597","volume":"34","author":"Chen","year":"2021","unstructured":"Chen et al. Cancer stemness Meets immunity: from mechanism to therapy. Cell. Rep. 34 (1), 108597 (2021).","journal-title":"Cell. Rep."},{"issue":"4","key":"24958_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.20892\/j.issn.2095-3941.2017.0083","volume":"14","author":"FK Collak","year":"2017","unstructured":"Collak, F. K. et al. Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension. Cancer Biol. Med. 14 (4), 405\u2013413 (2017).","journal-title":"Cancer Biol. Med."},{"key":"24958_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1515\/med-2020-0026","volume":"15","author":"Z Jin","year":"2020","unstructured":"Jin, Z. & Chen, B. LncRNA ZEB1-AS1 regulates colorectal cancer cells by MiR-205\/YAP1 axis. Open. Med. (Wars). 15, 175\u2013184 (2020).","journal-title":"Open. Med. (Wars)"},{"key":"24958_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ydbio.2020.12.018","volume":"475","author":"F Szulzewsky","year":"2021","unstructured":"Szulzewsky, F., Holland, E. C. & Vasioukhin, V. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev. Biol. 475, 205\u2013221 (2021).","journal-title":"Dev. Biol."},{"issue":"1","key":"24958_CR28","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1038\/s41467-023-37871-5","volume":"14","author":"XY He","year":"2023","unstructured":"He, X. Y. et al. LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism. Nat. Commun. 14 (1), 2253 (2023).","journal-title":"Nat. Commun."},{"issue":"1","key":"24958_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13046-020-01746-0","volume":"39","author":"H Yan","year":"2020","unstructured":"Yan, H. et al. Retraction Note: Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375\/YAP1 axis. J. Exp. Clin. Cancer Res. 39 (1), 233 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"24958_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13046-019-1356-z","volume":"38","author":"H Yan","year":"2019","unstructured":"Yan, H. et al. LncRNA FLVCR1-AS1 mediates miR-513\/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. J. Exp. Clin. Cancer Res. 38 (1), 356 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"24958_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cbpa.2017.10.008","volume":"41","author":"E Peer","year":"2017","unstructured":"Peer, E., Rechavi, G. & Dominissini, D. Epitranscriptomics: regulation of mRNA metabolism through modifications. Curr. Opin. Chem. Biol. 41, 93\u201398 (2017).","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"24958_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-019-1099-7","volume":"18","author":"BB Hu","year":"2019","unstructured":"Hu, B. B. et al. N(6)-methyladenosine (m(6)A) RNA modification in Gastrointestinal tract cancers: roles, mechanisms, and applications. Mol. Cancer. 18 (1), 178 (2019).","journal-title":"Mol. Cancer"},{"issue":"6","key":"24958_CR33","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen, M. et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional Silencing of SOCS2. Hepatology 67 (6), 2254\u20132270 (2018).","journal-title":"Hepatology"},{"key":"24958_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","volume":"415","author":"X Cai","year":"2018","unstructured":"Cai, X. et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett. 415, 11\u201319 (2018).","journal-title":"Cancer Lett."},{"issue":"1","key":"24958_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41420-021-00600-2","volume":"7","author":"X Bi","year":"2021","unstructured":"Bi, X. et al. METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246. Cell. Death Discov. 7 (1), 237 (2021).","journal-title":"Cell. Death Discov"},{"issue":"3","key":"24958_CR36","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.18632\/aging.202397","volume":"13","author":"XF Ni","year":"2021","unstructured":"Ni, X. F. et al. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1. Aging (Albany NY). 13 (3), 4357\u20134369 (2021).","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"24958_CR37","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.7150\/thno.51342","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization. Theranostics 11 (9), 4298\u20134315 (2021).","journal-title":"Theranostics"},{"issue":"2","key":"24958_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s43018-021-00315-4","volume":"3","author":"A Xia","year":"2022","unstructured":"Xia, A. et al. The cancer-testis LncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding HnRNP K and activating YAP1 transcription. Nat. Cancer. 3 (2), 203\u2013218 (2022).","journal-title":"Nat. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24958-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24958-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24958-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:26:11Z","timestamp":1763637971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24958-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24958-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Prior to starting this study, the consent of the Ethics Committee of Quanzhou First Hospital Affiliated to Fujian Medical University was obtained, and all involved patients were informed and volunteered to participate. All patients involved provided informed consent and volunteered to take part in this study. The study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0<!--Emphasis Type='Bold' removed-->and consent of participate"}}],"article-number":"41132"}}